GlobeNewsWire · ELTX · October 23, 2026

Elicio Therapeutics Presents Late-Breaking Phase 2 AMPLIFY-7P Results at ESMO Congress 2026 and Announces Simultaneous Publication in Nature Medicine

Get the app for more

Explore stock news, insights and company research.